There are several Methods to stop smoking, but not all work. This is because every smoker is different, and its mechanisms to quit depending on their nature, will and potential to do so. Thus, there is no universal method to quit smoking, but this could be one to prevent the return of ex-smoking habit.

This is a vaccine for smoking cessation, which arises from an agreement made by GlaxoSmithKline and Nabi Pharmaceuticals, two companies that have put the money to develop the NicVAX, a vaccine that is under development but could be on the market in a future.

The vaccine works by creating antibodies in the body, which trap the nicotine molecules and prevent them from reaching the brain through the blood, thus preventing the same cause the sensation of pleasure associated with smoking.

Since almost 90% of former smokers return to smoking a year of leaving, this vaccine could mean an outstanding solution for them. One of the challenges of ex-smoker is staying quit. This vaccine would ensure that, in the case of back to try a cigarette, ex-smokers feel no pleasure in doing so and therefore will not fall into the habit.